Cargando…
Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements
Neuroblastoma is the most common inheritable, solid neoplasm in children found under the age of 7 and accounts for approximately 7% of childhood cancers. A common treatment that has been prescribed for over a decade is retinoid therapy [using all-trans retinoic acid (RA)]. Treatment with this differ...
Autores principales: | Illendula, Abhinav, Fultang, Norman, Peethambaran, Bela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388440/ https://www.ncbi.nlm.nih.gov/pubmed/32705280 http://dx.doi.org/10.3892/or.2020.7681 |
Ejemplares similares
-
ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
por: Fultang, Norman, et al.
Publicado: (2020) -
Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
por: Fultang, Norman, et al.
Publicado: (2019) -
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma
por: Higashi, Mayumi, et al.
Publicado: (2015) -
Retinoic Acid Induces Functionally Suppressive Foxp3(+)RORγt(+) T Cells In Vitro
por: Martínez-Blanco, Mónica, et al.
Publicado: (2021) -
Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor
por: Hämmerle, Barbara, et al.
Publicado: (2013)